Abstract
Recent advances in high throughput screening technologies have accelerated the identification and characterization of potential factors involved in host-virus interactions, facilitating early detection and diagnosis of diseases, as well as providing promising drug targets. The last decade has seen a plethora of successful examples of high throughput screening approaches, especially siRNA screening. With support from protein interaction studies, mRNA expression profiling, and bioinformatics, siRNA screening has also been successfully utilized to identify host factors required for a number of viruses including HIV, West Nile virus and H1N1 virus. Such studies have raised the awareness of virologists, and have opened a new chapter of global analysis of host-pathogen interactions. However, to play a more defining role in prognostics, diagnostics and therapeutics for virus diseases, acknowledged drawbacks, including false positives and negatives, inherent in this technology, must be successfully addressed.
Keywords: Drug target, host factor, pathogen, siRNA, virus, Mycobacterium tuberculosis, high throughput screening, prognostics, hepatitis B virus, infection, hepatocellular carcinoma, replication, genome, viral life cycle, expression, host proteins
Combinatorial Chemistry & High Throughput Screening
Title: The Application of High Throughput siRNA Screening Technology to Study Host-Pathogen Interactions
Volume: 15 Issue: 4
Author(s): Li Ou, Dan Duan, Jinhua Wu, Edouard Nice and Canhua Huang
Affiliation:
Keywords: Drug target, host factor, pathogen, siRNA, virus, Mycobacterium tuberculosis, high throughput screening, prognostics, hepatitis B virus, infection, hepatocellular carcinoma, replication, genome, viral life cycle, expression, host proteins
Abstract: Recent advances in high throughput screening technologies have accelerated the identification and characterization of potential factors involved in host-virus interactions, facilitating early detection and diagnosis of diseases, as well as providing promising drug targets. The last decade has seen a plethora of successful examples of high throughput screening approaches, especially siRNA screening. With support from protein interaction studies, mRNA expression profiling, and bioinformatics, siRNA screening has also been successfully utilized to identify host factors required for a number of viruses including HIV, West Nile virus and H1N1 virus. Such studies have raised the awareness of virologists, and have opened a new chapter of global analysis of host-pathogen interactions. However, to play a more defining role in prognostics, diagnostics and therapeutics for virus diseases, acknowledged drawbacks, including false positives and negatives, inherent in this technology, must be successfully addressed.
Export Options
About this article
Cite this article as:
Ou Li, Duan Dan, Wu Jinhua, Nice Edouard and Huang Canhua, The Application of High Throughput siRNA Screening Technology to Study Host-Pathogen Interactions, Combinatorial Chemistry & High Throughput Screening 2012; 15 (4) . https://dx.doi.org/10.2174/138620712799361834
DOI https://dx.doi.org/10.2174/138620712799361834 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Polymeric Nanoparticles for Ophthalmic Drug Delivery: An Update on Research and Patenting Activity
Recent Patents on Nanomedicine Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses
Recent Patents on Anti-Cancer Drug Discovery Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Natural Polyphenols and Cardioprotection
Mini-Reviews in Medicinal Chemistry Immunomodulatory Drugs: IMiDs in Acute Myeloid Leukemia (AML)
Current Drug Targets Progress of Biological Agents on Psoriatic Arthritis
Current Pharmaceutical Biotechnology Targeted Delivery of Anti-Inflammatory Agents to Tumors
Current Pharmaceutical Design Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes
Current Medicinal Chemistry HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET
Current Drug Targets The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery Obesity-Driven Inflammation and Colorectal Cancer
Current Medicinal Chemistry Matrix Metalloproteinases
Current Medicinal Chemistry Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment
Current HIV Research Genetics and Molecular Biology of Tuberous Sclerosis Complex
Current Genomics Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases
Current Genomics Metabolic Homeostasis and Colonic Health: the Critical Role of Short Chain Fatty Acids
Current Nutrition & Food Science Seasonal and Perennial Allergic Conjunctivitis
Recent Patents on Inflammation & Allergy Drug Discovery Intestinal Immunomodulation. Role of Regulative Peptides and Promising Pharmacological Activities
Current Pharmaceutical Design The Pharmacogenetics of Asthma Therapy
Current Drug Targets